“Targeted science for healthier futures.”
Discover emerging research across oligonucleotide therapeutics, RNA therapeutics, mRNA, and next-generation delivery at OTDC 2027.
May 11–12, 2027 | Boston, MA | In-Person & Virtual
🌐
#OTDC2027# #RNA# #DrugDelivery#
From molecules to medicines, the path forward is shaped by innovation in oligonucleotide therapeutics, RNA medicines, and delivery technologies.
📅 May 11–12, 2027 | 📍 Boston, MA & Virtual
🔗
#OTDC2027# #Oligonucleotides# #RNAtherapeutics# #DrugDelivery#
Novo Nordisk signed a deal worth as much as €1.165 billion with Sweden’s Nanexa for rights to its drug delivery technology for obesity and diabetes treatments
⏰ The deadline is TODAY!
Register for OTDC 2027 and connect with advances in Oligonucleotide Therapeutics, RNA Technologies, Drug Delivery, CRISPR & Aptamer Technologies.
📅 May 11–12, 2027 | Boston + Hybrid
🔗
#OTDC2027# #Oligonucleotides# #RNA#
From molecular insights to life-changing therapies 🧬
OTDC 2027 brings together emerging advances in Oligonucleotide Therapeutics, RNA Technologies, Drug Delivery, CRISPR & Aptamer Technologies.
📅 May 11–12, 2027
📍 Boston | Hybrid
🔗
#OTDC2027#